The EuroPCR 2023 is coming

EuroPCR 2023, one of the most important events in interventional cardiology, will be held in Paris, France, on May 16 – 19, 2023. 

EuroPCR 2023

Organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), is aimed at interventional cardiologists, heart surgeons, interventional radiology and imaging technicians, nurses and related professionals.  

During this dynamic immersive 4-day course, you will find all you need to catch up with the latest in your field, improve your daily practice, your skills, benefit from excellent opportunities to network, and much more. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Save the Date! CardioInterv 2025 – 25th International Symposium on Interventional Cardiology is Coming

From November 26 to 28, 2025, the 25th International Symposium on Interventional Cardiology – CardioInterv 2025 will take place, a scientific excellence event that...

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one of the most relevant international meetings in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...